ストックスクリーナーアプリを入手
1.38
0.73%
0.010
前日終値:
$1.37
開ける：
$1.37
24時間の取引高:
1.20M
Relative Volume:
0.62
時価総額：
$84.72M
収益：
$5.03M
当期純損益:
$-185.41M
株価収益率:
-0.4466
EPS:
-3.09
ネットキャッシュフロー:
$-139.79M
1週間 パフォーマンス:
-2.13%
1か月 パフォーマンス:
-4.17%
6か月 パフォーマンス:
-88.90%
1年 パフォーマンス:
-91.16%
1日の値動き範囲:
$1.32
$1.43
1週間の範囲:
$1.32
$1.52
52週間の値動き範囲:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
名前
Pliant Therapeutics Inc
セクター
電話
650-481-6770
住所
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
PLRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.38 | 86.55M | 5.03M | -185.41M | -139.79M | -3.09 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-04 | 再開されました | Cantor Fitzgerald | Neutral |
| 2025-03-04 | ダウングレード | Needham | Buy → Hold |
| 2025-03-03 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | ダウングレード | Stifel | Buy → Hold |
| 2025-02-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-02-10 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-02-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-05-18 | 開始されました | Canaccord Genuity | Buy |
| 2023-04-13 | 開始されました | Robert W. Baird | Outperform |
| 2022-12-14 | 開始されました | Stifel | Buy |
| 2022-12-07 | 開始されました | JP Morgan | Overweight |
| 2022-09-01 | 開始されました | Citigroup | Buy |
| 2022-07-20 | 開始されました | SVB Leerink | Outperform |
| 2022-05-25 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 開始されました | Oppenheimer | Outperform |
| 2021-11-24 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-11-03 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-20 | 開始されました | BTIG Research | Buy |
| 2021-04-05 | 開始されました | Citigroup | Buy |
| 2020-06-29 | 開始されました | Citigroup | Buy |
| 2020-06-29 | 開始されました | Cowen | Outperform |
| 2020-06-29 | 開始されました | Needham | Buy |
| 2020-06-29 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Pliant Therapeutics Inc (PLRX) 最新ニュース
How Are Things Looking For Pliant Therapeutics Inc (NASDAQ: PLRX) For The Short Term? - Stocksregister
Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties - TipRanks
Another Bay Area biotech company announces layoffs - MSN
Pliant Therapeutics Reports Q1 2025 Financial Results - TipRanks
Pliant (PLRX) Prepares to Release Topline Results from BEACON-IP - GuruFocus
Pliant (PLRX) Prepares to Release Topline Results from BEACON-IPF Trial | PLRX Stock News - GuruFocus
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c) - TipRanks
Pliant Therapeutics (PLRX) Advances in Clinical Trials and Oncology Research | PLRX Stock News - GuruFocus
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewswire
Market Watch Highlights: Pliant Therapeutics Inc (PLRX) Ends on an Downturn Note at 1.43 - DWinneX
Pliant Therapeutics Cuts Workforce by Nearly Half - Powder & Bulk Solids
Bay Area biotech company Pliant Therapeutics slashes staff after losing $655 million in value - MSN
Pliant cuts workforce by 45% following lung trial termination - Clinical Trials Arena
Pliant Therapeutics to cut 45% of workforce (PLRX:NASDAQ) - Seeking Alpha
Pliant Therapeutics (PLRX) Restructures to Prolong Financial Res - GuruFocus
Pliant Therapeutics Reduces Workforce as Part of Strategic Realignment - MarketWatch
Pliant Therapeutics (PLRX) Restructures to Prolong Financial Resources | PLRX Stock News - GuruFocus
Pliant Therapeutics announces workforce reduction By Investing.com - Investing.com India
Pliant Therapeutics announces workforce reduction - Investing.com
Pliant Therapeutics Announces Major Workforce Reduction - TipRanks
Pliant Therapeutics Announces Workforce Reduction and Cost Saving Initiatives to Support Late-Stage Clinical Trials - Nasdaq
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewswire
Pliant Therapeutics Slashes Nearly Half its Workforce While Awaiting Crucial IPF Drug Results - Stock Titan
You might want to take a look at Pliant Therapeutics Inc (PLRX) now - Sete News
Pliant Therapeutics Inc [PLRX] stock was sold by Coulie Bernard at the price of US$0.59 million - knoxdaily.com
Market Momentum: Pliant Therapeutics Inc (PLRX) Registers a 0.68 Increase, Closing at 1.48 - DWinneX
Stock Performance Spotlight: Cg Oncology Inc (CGON) Ends the Day at 26.94, Down by -3.68 - DWinneX
Pliant Therapeutics Inc (PLRX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Legal & General Group Plc Grows Stock Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
Pliant Therapeutics Inc: A Year of Highs, Lows, and Market Resilience - investchronicle.com
Press Release Distribution & PR Platform - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc.PLRX - Louisiana First News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant ... - Bluefield Daily Telegraph
Pliant Therapeutics discovers new integrin αvβ1, αvβ6 and/or αvβ8 antagonists - BioWorld MedTech
Pliant Therapeutics Inc’s Market Journey: Closing Weak at 3.03, Down -1.62 - DWinneX
PLRXPliant Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Healthy Upside Potential: Pliant Therapeutics Inc (PLRX) - Sete News
Market Recap Check: Pliant Therapeutics Inc (PLRX)’s Positive Finish at 1.54, Up/Down 2.67 - DWinneX
Pliant Therapeutics Inc (PLRX)’s stock price in review: A technical analysis - uspostnews.com
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Shares Bought by JPMorgan Chase & Co. - Defense World
PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Pliant Therapeutics stock hits 52-week low at $1.2 amid sharp decline - Investing.com
Major Breakthrough: Pliant Reveals Latest Bexotegrast Research Data in Three Key Presentations - Stock Titan
Pliant Therapeutics Announces Upcoming Presentations at the - GlobeNewswire
Pliant Therapeutics Inc (PLRX) 財務データ
収益
当期純利益
現金流量
EPS
Pliant Therapeutics Inc (PLRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont | Chief Financial Officer |
Jan 17 '25 |
Sale |
11.20 |
20,148 |
225,680 |
262,608 |
| Hull Hans | Chief Business Officer |
Jan 17 '25 |
Sale |
11.20 |
15,936 |
178,501 |
211,558 |
| Lefebvre Eric | Chief Medical Officer |
Jan 17 '25 |
Sale |
11.20 |
18,478 |
206,974 |
194,574 |
| Cheung Lily | Chief Human Resource Officer |
Jan 17 '25 |
Sale |
11.20 |
3,740 |
41,892 |
24,550 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 17 '25 |
Sale |
11.20 |
13,270 |
148,639 |
80,774 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 22 '25 |
Sale |
10.99 |
10,230 |
112,462 |
70,544 |
1.54%
7.58%
大文字化:
|
ボリューム (24 時間):